BAC
Bank of America Corporation
BAC has slightly lower modeled downside risk, despite its lower overall score.
BY
Byline Bancorp, Inc.
BY has a slight edge over BAC overall on the model score.
BAC Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| N/A | |
| N/A |
BAC's revenue and profitability are currently healthy. Free cash flow and net leverage aren't meaningful measures for financial services companies like BAC.
BY Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Strong | |
| N/A | |
| N/A |
BY's profitability is currently strong, and its revenue is stable. Free cash flow and net leverage aren't meaningful measures for financial services companies like BY.
BAC PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 9.4x | $39.50 | -22% |
| Forward | 10x | $50.51 | — |
| Current | 12x | $50.51 | — |
| Fair | 13x | $53.81 | +6.5% |
| Expensive | 15x | $62.23 | +23% |
Historical ranges are pointers, not guarantees.
BAC has the edge over BY in the historical PE scenario, which offers more potential upside but is not a forecast.
BY PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 8.5x | $29.37 | -25% |
| Fair | 11x | $36.15 | -7.5% |
| Current | 11x | $39.07 | — |
| Forward | 11x | $39.07 | — |
| Expensive | 12x | $42.67 | +9.2% |
Historical ranges are pointers, not guarantees.
BY's PE is in its expensive range at 11.4x. On analysts' estimates for next year's earnings, today's price would be 11.2x, in its fair range.
BAC Forward outlook
| Metric | Outlook |
|---|---|
| Improving | |
| Growth | |
| Growth | |
| Strongly improving | |
| Limited | |
| Moderate |
BAC has the edge over BY on the outlook, with more favorable valuation expectations.
BY Forward outlook
| Metric | Outlook |
|---|---|
| Stable | |
| Growth | |
| Growth | |
| Improving | |
| Limited | |
| High |
Analysts expect earnings and revenue growth for BY, with profitability improving.
BAC Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $4.92 | +17% |
| Q3 2026 | $4.19 | +14% |
| Q2 2026 | $4.34 | +27% |
| Q1 2026 | $4.02 | +20% |
| Q4 2025 | $3.81 | +19% |
| Q3 2025 | $3.66 | +33% |
| Q2 2025 | $3.41 | +20% |
| Q1 2025 | $3.35 | +16% |
| Q4 2024 | $3.21 | +4.2% |
BAC has the edge over BY on earnings, with more consistent year-over-year improvement.
BY Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $3.48 | +1.2% |
| Q3 2026 | $3.44 | +23% |
| Q2 2026 | $3.32 | +24% |
| Q1 2026 | $3.08 | +14% |
| Q4 2025 | $2.89 | +5.1% |
| Q3 2025 | $2.80 | +1.8% |
| Q2 2025 | $2.67 | -1.5% |
| Q1 2025 | $2.69 | -1.5% |
| Q4 2024 | $2.75 | +3% |
BY earned $3.44 per share over the past year, up 23% from the year before.
BAC Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $30B | +6.7% |
| Q2 2026 | $31.6B | +19% |
| Q1 2026 | $30.3B | +11% |
| Q4 2025 | $31.2B | +23% |
| Q3 2025 | $28.1B | +11% |
| Q2 2025 | $26.5B | +4.3% |
| Q1 2025 | $27.4B | +6% |
| Q4 2024 | $25.3B | +15% |
BAC has the edge over BY on sales, with stronger typical year-over-year growth.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 30% | -3.7 points |
| Q2 2026 | 37% | +7.6 points |
| Q1 2026 | 34% | +4.7 points |
| Q4 2025 | 40% | +12 points |
| Q3 2025 | 34% | +4.8 points |
| Q2 2025 | 29% | -0.7 points |
| Q1 2025 | 30% | +1.5 points |
| Q4 2024 | 28% | +14 points |
BAC's operating margin was 30% last quarter, down 3.7 points from the same quarter a year ago.
BY Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $121M | +4.6% |
| Q2 2026 | $117.7M | +6.6% |
| Q1 2026 | $112.4M | +9% |
| Q4 2025 | $117M | +12% |
| Q3 2025 | $115.7M | +14% |
| Q2 2025 | $110.5M | +11% |
| Q1 2025 | $103.1M | +2% |
| Q4 2024 | $104.7M | +3.9% |
BY's revenue has grown year over year for eight quarters in a row: $121M last quarter, up 4.6% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 45% | +1.9 points |
| Q2 2026 | 46% | +11 points |
| Q1 2026 | 44% | +7.8 points |
| Q4 2025 | 40% | +1.5 points |
| Q3 2025 | 43% | +3.8 points |
| Q2 2025 | 35% | -5.1 points |
| Q1 2025 | 36% | -3.8 points |
| Q4 2024 | 39% | -1.1 points |
BY has the edge over BAC on profitability, with a higher operating margin.
BAC Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$6.5B | -114% |
| Q2 2026 | $29B | +$38.2B |
| Q1 2026 | $41.8B | +$44B |
| Q4 2025 | -$22.9B | -189% |
| Q3 2025 | $46.9B | +$84.2B |
| Q2 2025 | -$9.1B | -150% |
| Q1 2025 | -$2.2B | +$13.4B |
| Q4 2024 | $25.9B | -21% |
BAC's free cash flow was $41.4B over the past year, down 33% from the year before. Free cash flow isn't a meaningful measure for financial services companies like BAC.
BY Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $61.7M | +63% |
| Q2 2026 | $13.2M | -13% |
| Q1 2026 | $54.1M | +116% |
| Q4 2025 | $58.1M | +14% |
| Q3 2025 | $38M | +98% |
| Q2 2025 | $15.2M | -61% |
| Q1 2025 | $25M | -59% |
| Q4 2024 | $50.8M | +$56.8M |
BY has the edge over BAC on cash flow, with more consistent year-over-year improvement.
BAC Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -1% | -72M shares |
| 1 year | -5.3% | -405M shares |
| 3 years | -11% | -854M shares |
| 5 years | -15% | -1.3B shares |
| Available history | -24% | -2.2B shares |
BAC has the edge over BY on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $6B |
| Q2 2026 | $6B |
| Q1 2026 | $7.2B |
| Q4 2025 | $6.3B |
| Q3 2025 | $5.3B |
| Q2 2025 | $5.3B |
| Q1 2025 | $4.5B |
| Q4 2024 | $3.5B |
BAC spent $25.6B buying back its own shares over the past year, up 37% from the year before.
BY Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.6% | -247K shares |
| 1 year | -1.8% | -831K shares |
| 3 years | +2.5% | +1.1M shares |
| 5 years | +17% | +6.5M shares |
| Available history | +17% | +6.6M shares |
BY has 45M diluted shares, down 1.8% from a year ago, with $49M in buybacks over the past year.
| Quarter | Spent |
|---|---|
| Q3 2026 | $20.2M |
| Q2 2026 | $9.1M |
| Q1 2026 | $9.8M |
| Q4 2025 | $9.8M |
| Q3 2025 | $193,000 |
| Q2 2025 | $13.1M |
| Q1 2025 | $687,000 |
| Q4 2023 | — |
BY spent $49M buying back its own shares over the past year.
BAC Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 6.4x | High |
| Q2 2026 | 6.7x | High |
| Q1 2026 | 7.1x | High |
| Q4 2025 | 7.7x | High |
| Q3 2025 | 8.3x | High |
| Q2 2025 | 8.8x | High |
| Q1 2025 | 8.6x | High |
| Q4 2024 | 9.0x | High |
BAC's net debt is about 6.4 years of its operating earnings (EBITDA), down from 8.3 years a year ago. Net leverage isn't a meaningful measure for financial services companies like BAC.
BY Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 1.6x | Healthy |
| Q2 2026 | 3.5x | Elevated |
| Q1 2026 | 4.2x | High |
| Q4 2025 | 3.9x | Elevated |
| Q3 2025 | 3.3x | Elevated |
| Q2 2025 | 4.0x | High |
| Q1 2025 | 4.8x | High |
| Q4 2024 | 4.3x | High |
BY has the edge over BAC on leverage, with a lower net debt burden relative to earnings.
BAC Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 37.1 | Neutral |
| Stochastic | 4.9 | Oversold |
BAC's weekly RSI is 37 (neutral) and its Stochastic is 5 (oversold).
BY Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 62.6 | Neutral |
| Stochastic | 64.4 | Neutral |
BY's weekly RSI is 63 (neutral) and its Stochastic is 64 (neutral).
BAC PE vs Financial Services Sector
| Metric | BAC | Sector median | Relative |
|---|---|---|---|
| PE | 12x | 13x | 7.5% below |
| PE % | 40 | 63 | 23 pts below |
BAC is trading at 12x earnings, in line with the Financial Services sector's median of 13x.
BY PE vs Financial Services Sector
| Metric | BY | Sector median | Relative |
|---|---|---|---|
| PE | 11x | 13x | 13% below |
| PE % | 67 | 63 | 4 pts above |
BY has the edge over BAC on valuation relative to its sector.
BAC Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $52.1 | 3% below |
| 20 week MA | $57.8 | 13% below |
| 50 week MA | $54.7 | 7.7% below |
| 100 week MA | $50.5 | 0% below |
| 200 week MA | $42.5 | 19% above |
BAC has fallen below most of its moving averages, though it's still 19% above its 200-week average.
BY Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $37.9 | 3.2% above |
| 20 week MA | $38.2 | 2.4% above |
| 50 week MA | $34.5 | 13% above |
| 100 week MA | $30.9 | 26% above |
| 200 week MA | $26.8 | 46% above |
BY has the edge over BAC on trend strength, trading above more of its moving averages.
BAC Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $35.4 | $30.0 | -15% |
| 2021 | $30.0 | $44.4 | +48% |
| 2022 | $44.4 | $32.5 | -27% |
| 2023 | $32.5 | $33.7 | +3.7% |
| 2024 | $33.7 | $44.3 | +32% |
| 2025 | $44.3 | $56.2 | +27% |
| 2026 YTD | $56.2 | $50.5 | -10% |
BAC has finished higher in four of the last six years. It's down 10% so far in 2026.
BY Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $19.3 | $15.4 | -20% |
| 2021 | $15.4 | $26.9 | +74% |
| 2022 | $26.9 | $22.9 | -15% |
| 2023 | $22.9 | $23.6 | +2.8% |
| 2024 | $23.6 | $29.0 | +23% |
| 2025 | $29.0 | $29.7 | +2.6% |
| 2026 YTD | $29.7 | $39.1 | +32% |
BY has the edge over BAC on returns for 2026, with the stronger performance.